Managing Patient Preferences and Expectations in Frontline EGFR-Mutant NSCLC

This segment turns from data to the patient conversation, focusing on the preconceptions people bring to treatment decisions. The faculty discuss how many patients arrive determined to avoid chemotherapy, or especially worried about visible effects such as rash, and how clinicians can meet those concerns with education rather than simply defer to them. A central point is that modern first-line chemotherapy is often better tolerated than patients expect from older experiences, while the chemotherapy-free combination carries its own substantial, if different, burden and can demand a near full-time commitment to preventive skin and supportive care. The panel describes weighing disease biology and risk features alongside the patient's life circumstances, preferences, and practical constraints such as travel, cost, and adherence capacity. The discussion underscores that these are often multi-visit conversations requiring time, clear communication, and genuine shared decision-making to reach the right individualized choice.